drugset / Trial / NCT05944757

Compare of PRP Autologous Serum and Autologous Serum by Intrastromal Injection in Different Eye Disease Conditions

NCT05944757

Unknown 40 enrolled Anita Syla Lokaj
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Platelet-rich plasma (PRP) is an autologous blood product rich in proteins and growth factors. Its application has been the subject of many studies in the field of ophthalmology to stimulate tissue healing and regeneration. Due to its anatomical features (lack of blood vessels), the cornea is among the most susceptible to damage structures of the eye. Therefore, the study of the impact of various regenerative therapies (autologous blood products, serums, ) on corneal lesions is important not only scientifically, but also practically for ophthalmologist. Numerous reports described the healing effect of PRP on corneal lesions.

Timeline

Start
2021-09-01
Primary completion
2023-09-01
Completion
2024-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous serum Unknown 0.5 ml Other
Subject PRP plasma rich platelets Unknown 0.5 ml Other

Indications

No indication recorded.